Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea
RaDAR-Go
1 other identifier
observational
261
1 country
3
Brief Summary
The purpose of this study is to develop a laboratory-based assay that will be a real-time PCR test to detect the organism N. gonorrhoeae and its most important genetic markers of antimicrobial resistance. This study will also determine factors associated with gonorrhoea and describe sexual behaviours of men who have sex with men, to inform parameters for a mathematical model of gonorrhoea transmission and antimicrobial resistant gonorrhoea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2015
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2015
CompletedFirst Posted
Study publicly available on registry
January 30, 2015
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedJuly 16, 2019
July 1, 2019
1.3 years
January 20, 2015
July 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of N. gonorrhoeae genetic markers for antimicrobial resistance in clinical specimens
Day of specimen sampling
Eligibility Criteria
Adult male and females at risk of gonorrhoea infection.
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study.
- Male or female, aged 18 years or above.
- Participant is literate in German, French, English or Hungarian.
- Participant is at risk for a N. gonorrhoeae infection. This is defined as:
- exhibiting signs/symptoms of a N. gonorrhoeae infection.
- having a sexual partner who has been diagnosed with a N. gonorrhoeae infection.
- participating in high-risk activities for a N. gonorrhoeae infection.
You may not qualify if:
- Subject does not agree to undergo diagnostic test for gonorrhoea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University Hospital of Bern
Bern, 3010, Switzerland
Ambulatorium Kanonengasse
Zurich, 8004, Switzerland
Checkpoint Zurich
Zurich, 8005, Switzerland
Related Publications (5)
Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med. 2014 Feb 4;11(2):e1001598. doi: 10.1371/journal.pmed.1001598. eCollection 2014 Feb.
PMID: 24503544BACKGROUNDFingerhuth SM, Bonhoeffer S, Low N, Althaus CL. Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners. PLoS Pathog. 2016 May 19;12(5):e1005611. doi: 10.1371/journal.ppat.1005611. eCollection 2016 May.
PMID: 27196299BACKGROUNDDona V, Kasraian S, Lupo A, Guilarte YN, Hauser C, Furrer H, Unemo M, Low N, Endimiani A. Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae. J Clin Microbiol. 2016 Aug;54(8):2074-81. doi: 10.1128/JCM.03354-15. Epub 2016 May 25.
PMID: 27225407BACKGROUNDLow N, Unemo M. Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? Curr Opin Infect Dis. 2016 Feb;29(1):45-51. doi: 10.1097/QCO.0000000000000230.
PMID: 26658656BACKGROUNDDona V, Smid JH, Kasraian S, Egli-Gany D, Dost F, Imeri F, Unemo M, Low N, Endimiani A. Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens. J Clin Microbiol. 2018 Aug 27;56(9):e00365-18. doi: 10.1128/JCM.00365-18. Print 2018 Sep.
PMID: 29950339RESULT
Biospecimen
Swabs from the urethra, rectum, oropharynx, vagina and endocervix
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicola Low
University of Bern, Institute of Social and Preventive Medicine
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2015
First Posted
January 30, 2015
Study Start
February 1, 2015
Primary Completion
June 1, 2016
Study Completion
August 1, 2016
Last Updated
July 16, 2019
Record last verified: 2019-07